echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > Clin Trans Gastroenterology: Regenerative liver 3phosphatase in circulating tumor cells may be an important prognostic marker for evaluating recurrence or metastasis in patients with colorectal cancer

    Clin Trans Gastroenterology: Regenerative liver 3phosphatase in circulating tumor cells may be an important prognostic marker for evaluating recurrence or metastasis in patients with colorectal cancer

    • Last Update: 2020-12-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The most common metastatic target organ for colorectal cancer (CRC) is the liver.
    the initial diagnosis found that about 15% to 20% of CRC patients have liver metastasis, the remaining 60% of patients in subsequent treatment will also appear liver metastasis or tumor recurrence, which is the CRC treatment of poor efficacy and the main cause of death.
    overextendation of phosphatases in regenerative liver 3 (PRL-3) and endoskine-interstitium transformation (EMT) is considered to be the most important factor affecting distant metastasis of tumor cells, and is associated with CRC migration, invasion and metastasis.
    in this study, the researchers used CanPatrol CTC rich technology and PRL-3 antibody probes to pinn up mobile tumor cells (TCCs) and divided CTC into three sub-groups, namely, the skin CTC with PRL-3 (E-PRL) -3 plus CTC), dual esothype overskin/interstate with PRL-3 CTC (E s/ M s PRL-3 s CTC) and interstate CTC with PRL-3 (M s PRL-3 s CTC).
    study aims to explore the prognostic significance of PRL-3 (M -PRL-3 plus CTC) and interstitcharged CTC in postoperative CRC patients.
    researchers tested CTC subtypes (including endothystic CTC, double esothypeal/intersuper charge CTC and interstate CTC) and PRL-3 from exothentic blood samples from 156 patients.
    then performed subject work characteristic curve analysis, Kaplan-Meier analysis, and Cox proportional risk regression analysis to identify the prognostic value of PRL-3 plus interstit rated CTCs.
    immunologic tissue chemistry is used to detect the expression of PRL-3 in some patients' tumor tissues to explore the link between CTC and tissue.
    found that all CTC in all samples were positive, as were interstate CTC and PRL-3-positive cells.
    the count of interstate charge and PRL-3 plus CTC is significantly corred with recurrence, with an optimal threshold of 2 (area below the curve: 0.690, P -lt;0.001).
    addition, based on multivariable and polynolytic logic regression, the median survival of these patients was significantly shorter than that of patients who did not meet the standards (8.5 vs 24 months, P .lt;0.001).
    , this study confirms that the status of M-PRL-3-plus in CTC may be an important prognosmical indicator for evaluating CRC clinical outcomes.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.